A Phase 3, Randomized, Double Blind, Placebo And Active‑Controlled, Multicenter, Parallel‑Group Study Of The Analgesic Efficacy And Safety Of Tanezumab In Adult Subjects With Chronic Low Back Pain
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 16 Mar 2018
At a glance
- Drugs Tanezumab (Primary) ; Tramadol
- Indications Back pain
- Focus Registrational; Therapeutic Use
- Acronyms TANGO
- Sponsors Pfizer
- 13 Mar 2018 Planned End Date changed from 8 Jan 2019 to 1 Jan 2019.
- 27 Nov 2017 Status changed from suspended to active, no longer recruiting.
- 20 Nov 2017 Status changed from active, no longer recruiting to suspended.